A new pathologic classification scheme for diabetic nephropathy, in which only glomerular lesions are used to classify renal damage associated with either type 1 or type 2 diabetes, has been developed in association with the Renal Pathology Society. Given the heterogeneity of the renal lesions underlying diabetic nephropathy and the complex natural history of the disease, this scheme is not yet ready for clinical application but should be considered an important first step towards the development of a clinically useful classification system.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Protective and health-promoting impact of Washingtonia filifera oil on the kidney of STZ-induced diabetic mice
Applied Biological Chemistry Open Access 25 June 2022
-
Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations
Journal of Nephrology Open Access 17 July 2020
-
Renal structure in type 2 diabetes: facts and misconceptions
Journal of Nephrology Open Access 12 July 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Tervaert, T. W. et al. Pathologic classification of diabetic nephropathy. J. Am. Soc. Nephrol. 21, 556–563 (2010).
Parving, H.-H., Mauer, M. & Ritz, E. In Brenner & Rector's The Kidney, 7th edn (ed. Brenner, B. M). 1777–1818 (Saunders, Philadelphia, 2004).
Fioretto, P., Caramori, M. L. & Mauer, M. The kidney in diabetes: dynamic pathways of injury and repair. Diabetologia 51, 1347–1355 (2008).
Osterby, R. et al. Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36, 1064–1070 (1993).
Fioretto, P. et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39, 1569–1576 (1996).
Gambara, V., Mecca, G., Remuzzi, G. & Bertani, T. Heterogeneous nature of renal lesions in type II diabetes. J. Am. Soc. Nephrol. 3, 1458–1466 (1993).
Mauer, S. M. et al. Structural–functional relationships in diabetic nephropathy. J. Clin. Invest. 74, 1143–1155 (1984).
Urizar, R. E, Schwartz, A., Top F. Jr & Vernier, R. L. The nephrotic syndrome in children with diabetes mellitus of recent onset. N. Engl. J. Med. 281, 173–181 (1969).
Najafian, B., Crosson, J. T., Kim, Y. & Mauer, M. Glomerulotubular junction abnormalities are associated with proteinuria in type 1 diabetes. J. Am. Soc. Nephrol. 17 (Suppl. 2), S53–S60 (2006).
Harris, R. D., Steffes, M. W., Bilous, R. W., Sutherland, D. E. & Mauer, S. M. Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int. 40, 107–114 (1991).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Fioretto, P., Mauer, M. Diabetic nephropathy—challenges in pathologic classification. Nat Rev Nephrol 6, 508–510 (2010). https://doi.org/10.1038/nrneph.2010.96
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2010.96
This article is cited by
-
Protective and health-promoting impact of Washingtonia filifera oil on the kidney of STZ-induced diabetic mice
Applied Biological Chemistry (2022)
-
Berberine Improves the Protective Effects of Metformin on Diabetic Nephropathy in db/db Mice through Trib1-dependent Inhibiting Inflammation
Pharmaceutical Research (2021)
-
Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations
Journal of Nephrology (2020)
-
Renal structure in type 2 diabetes: facts and misconceptions
Journal of Nephrology (2020)
-
C1-Ten is a PTPase of nephrin, regulating podocyte hypertrophy through mTORC1 activation
Scientific Reports (2017)